REGENLIFE
French tech company | Builders Republic
About
Developer of photobiomodulation medical devices for neurodegenerative diseases — its RGn helmet and abdominal belt deliver calibrated near-infrared light to the brain and gut, targeting Alzheimer's disease, currently in clinical trials.
Key facts
- Status
- Active
- Sectors
- Healthcare & Life Sciences
- Latest stage
- Series A
- Founded
- 2016
- City
- PARIS
- Region
- Occitanie
- Tracked rounds
- 1
- Amount raised
- 3.0 M€ raised since 2020
Funding rounds
- Series A — 2023